ClinicalTrials.govpublic full text
Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer
gastric cancer, 1st line treatment for gastric cancer, cetuximab, capecitabine, xeloda, cisplatin, progression-free survival, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876649
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.